The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Evolent Health Inc (NYSE: EVH) was $9.9 for the day, up 5.21% from the previous closing price of $9.41. In other words, the price has increased by $5.21 from its previous closing price. On the day, 2.0 million shares were traded. EVH stock price reached its highest trading level at $9.945 during the session, while it also had its lowest trading level at $9.37.
Ratios:
Our analysis of EVH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 0.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On December 03, 2024, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $36 to $29.
Stephens Downgraded its Overweight to Equal-Weight on November 08, 2024, whereas the target price for the stock was revised from $38 to $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’25 when Holder Diane bought 2,735 shares for $9.33 per share. The transaction valued at 25,518 led to the insider holds 70,584 shares of the business.
McCarthy Daniel Joseph bought 11,040 shares of EVH for $99,470 on Mar 06 ’25. The PRESIDENT now owns 389,004 shares after completing the transaction at $9.01 per share. On Mar 07 ’25, another insider, Jelinek Richard M, who serves as the Director of the company, bought 30,000 shares for $9.12 each. As a result, the insider paid 273,750 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 1162259968 and an Enterprise Value of 1963814016. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 0.819 whereas that against EBITDA is 23.259.
Stock Price History:
The Beta on a monthly basis for EVH is 0.80, which has changed by -0.5588235 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, EVH has reached a high of $33.63, while it has fallen to a 52-week low of $7.06. The 50-Day Moving Average of the stock is 3.45%, while the 200-Day Moving Average is calculated to be -15.44%.
Shares Statistics:
EVH traded an average of 2.61M shares per day over the past three months and 2840300 shares per day over the past ten days. A total of 115.86M shares are outstanding, with a floating share count of 114.13M. Insiders hold about 2.78% of the company’s shares, while institutions hold 108.18% stake in the company. Shares short for EVH as of 1752537600 were 17547667 with a Short Ratio of 6.71, compared to 1749772800 on 15225384. Therefore, it implies a Short% of Shares Outstanding of 17547667 and a Short% of Float of 15.129999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
